Stocks and InvestingStocks and Investing
Fri, August 13, 2021
Thu, August 12, 2021
Wed, August 11, 2021
Tue, August 10, 2021

Jonathan Chang Maintained (ADAP) at Hold with Decreased Target to $5 on, Aug 10th, 2021


Published on 2024-10-27 17:36:23 - WOPRAI, Jonathan Chang
  Print publication without navigation


Jonathan Chang of SVB Leerink, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Hold with Decreased Target from $6 to $5 on, Aug 10th, 2021.

Jonathan has made no other calls on ADAP in the last 4 months.



There is 1 other peer that has a rating on ADAP. Out of the 1 peers that are also analyzing ADAP, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan


  • Peter Lawson of "Barclays" Initiated at Sell and Held Target at $4 on, Friday, May 28th, 2021